Need professional-grade analysis? Visit stockanalysis.com
$4.24B
0.43
4,963
2.52%
Price Chart
Risk-Adjusted Performance
Also Listed On
Glanbia plc (GLB) Price Performance
Glanbia plc (GLB) trades on London Stock Exchange in EUR. The company is classified in the Consumer Defensive sector under the Packaged Foods industry. The stock currently trades at EUR17.05, down 3.67% from the previous close.
Over the past year, GLB has traded between a low of EUR8.99 and a high of EUR18.00. The stock has gained 70.9% over this period. It is currently 5.3% below its 52-week high.
Glanbia plc has a market capitalization of $4.24B, with a price-to-earnings ratio of 0.43 and a dividend yield of 2.52%.
About Glanbia plc
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Company Info
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Exchange
- London Stock Exchange
- Currency
- EUR
- Country
- United Kingdom
Financial Metrics
- Revenue (TTM)
- $3.95B
- EBITDA
- $452.00M
- Profit Margin
- 4.65%
- EPS (TTM)
- 0.41
- Book Value
- 6.93
Technical Indicators
- 52 Week High
- €18.00
- 52 Week Low
- €8.99
- 50 Day MA
- €16.42
- 200 Day MA
- €14.50
- Beta
- 0.47
Valuation
- Trailing P/E
- 0.43
- Forward P/E
- 12.99
- Price/Sales
- 1.07
- Price/Book
- 2.38
- Enterprise Value
- $4.93B